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Summary
According to the World Health Organization, overweight and obesity are deﬁned
as abnormal or excessive fat accumulation that presents a risk to health. What
constitutes ‘abnormal’ fat accumulation in this deﬁnition is not speciﬁed, but this
most likely represents a consensus term that encapsulates the importance of
adipose tissue dysfunctions, rather than solely excess fat per se, in the pathogen-
esis of disease entities of the metabolic syndrome, particularly type 2 diabetes and
cardiovascular diseases. Over the past decades, such abnormalities in fat accumu-
lation have been linked to a pattern of fat distribution characterized by dispro-
portionate fat deposition in the abdomen; to limits in the capacity of adipose
tissue to expand resulting in the burden of fat storage being shifted to ‘lean’
tissues/organs as ectopic fat; and to the secretion (by both intrinsic and inﬁltrated
cells within the adipose tissue mass) of a plethora of cytokines and other factors
which via their autocrine, paracrine and/or endocrine actions underscore a state of
chronic low-grade inﬂammation. These links have formed the basis of a multitude
of adipocentric concepts that have stimulated basic and clinical research aimed at
explaining differential susceptibilities to cardiometabolic diseases according to
diet and lifestyle, birth weight and post-natal growth patterns, menopausal tran-
sition and the ageing process, race and ethnicity – often within the framework of
hypotheses constructed around thrifty genotypes or thrifty phenotypes, and
around overlapping molecular pathways implicated in metabolic inﬂammation,
thermogenesis and body composition regulation. It is against this background of
rapidly advancing research in metabolic health – fuelled as much by the search for
early markers of cardiometabolic risks as by the search for ‘druggable’ molecular
targets for treating obesity and its comorbidities – that fundamental concepts,
controversies and novel research avenues relevant to the theme of ‘Body compo-
sition, Inﬂammation and Thermogenesis in Pathways to Obesity and the Meta-
bolic Syndrome’ are addressed in this overview and the 10 review articles in this
supplement reporting the proceedings of the 6th Fribourg Obesity Research
Conference (FORC-2011).
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Introduction
The 6th Fribourg Obesity Research Conference (FORC-
2011), which was attended by about 100 researchers from
both academia and industry based in Switzerland, once
again provided a platform for scientists in both basic
science and clinical medicine to present and discuss some of
the rapidly advancing scientiﬁc ﬁndings in obesity and
metabolic health from a perspective of integrative physiol-
ogy and nutrition. Its proceedings consist of a total of 10
review articles (Table 1), which, together with abstracts of
poster sessions, are published in this supplement. An over-
view of the topics and main issues addressed at this con-
ference and in the review articles is provided below.
Physical and functional phenotyping
From a historical perspective, research towards under-
standing how obesity predisposes to chronic metabolic dis-
eases and the metabolic syndrome has been dominated by
concepts centred upon the speciﬁc anatomical locations at
which fat accumulates in the body. In the 1950s, Vague (1)
proposed that excess fat stored on the trunk or android
obesity could be metabolically more damaging than fat
stored on the limbs (or gynoid obesity). This proposal has
been conﬁrmed by a large number of cross-sectional and
prospective studies, and it is now recognized that abdomi-
nal (or central) obesity is a cardinal feature of the metabolic
syndrome, with insulin resistance as a key link between
abdominal fat and risks for chronic diseases. Whether spe-
ciﬁc anatomical compartments in the abdominal region
(intra-abdominal, visceral, deep subcutaneous) or other
body composition phenotypes (e.g. low muscle mass,
ectopic lipid inﬁltration) confer greater risk for insulin
resistance and its complications is however uncertain (2).
As emphasized by Müller et al. in this supplement, the
tracking of body composition in the pathogenesis of obesity
and the metabolic syndrome has to take into account
the diversity of body composition phenotypes even within
subgroups of obese individuals such as those classiﬁed
as ‘metabolically healthy’ and ‘metabolically abnormal’, as
well as within normal-weight individuals classiﬁed as
‘thin-outside fat-inside’ or ‘sarcopenic obese’ characterized
by a high fat mass and low muscle mass. The arguments
are put forward that, faced with the results of dynamic
phenotyping (by under- and overfeeding) in lean healthy
men showing large inter-individual variability in ‘metabolic
ﬂexibility’ (i.e. changes in insulin sensitivity related to
insulin secretion) and ‘b-cell plasticity’ (i.e. insulin secretion
related to insulin sensitivity), it may be necessary to deﬁne
a metabolically healthy vs. a pathological state by dynamic
rather than static phenotyping using both physical (body
Table 1 Presentation list
Invited speaker and institution Authors and title of review articles
Manfred Müller Müller M., Lagerpusch M., Enderle J., Schautz B., Heller M. & Bosy-Westphal A.
Christian-Albrechts University, Kiel, Germany Beyond the BMI – tracking body composition in pathogenesis of obesity and metabolic syndrome
Jonathan Wells Wells J.C.K.
Institute of Child Health, London, UK Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of
ethnicity, including those of mixed ethnicity
Daniel Konrad Item F. & Konrad D.
University Children’s Hospital, Zurich, CH Visceral fat and metabolic inﬂammation: the portal theory revisited
Francesca Amati Amati F.
University of Lausanne, CH Revisiting the diacylglycerol-induced insulin resistance hypothesis
Yves Boirie Guillet G., Masgrau A., Walrand S. & Boirie Y.
University of Clermont, France Impaired protein metabolism: interlinks between obesity, insulin resistance and inﬂammation
Zhihong Yang Yang Z. & Ming X-F.
University of Fribourg, CH mTOR signaling: the molecular interface connecting metabolic stress, aging, and cardiovascular
diseases
Giovanni Solinas Solinas G.
University of Fribourg, CH Molecular pathways linking metabolic inﬂammation and thermogenesis
Saverio Cinti Smorlesi A., Frontini A., Giordano A. & Cinti S.
University of Ancona, Italy The adipose organ: white-brown adipocyte plasticity and metabolic inﬂammation
Lewis Landsberg Landsberg L.
Northwestern University, Chicago, USA Core temperature: a forgotten variable in energy expenditure and obesity?
Abdul Dulloo Dulloo A.G., Jacquet J., Montani J-P. & Schutz Y.
University of Fribourg, CH Adaptive thermogenesis in human body weight regulation: more of a concept than a measurable
entity?
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composition) and functional (metabolic, endocrinological
and immunological) criteria, and that such approaches will
also provide a suitable basis for future genomic research.
The issue of diversity in body composition phenotypes
and cardiometabolic risks is also analyzed by Wells, who
explored how body composition variability, and in particu-
lar its life-course development, may contribute to cardi-
ometabolic risk, and how this scenario may be particularly
valuable for understanding ethnic variability in cardi-
ometabolic risk. Indeed, minority ethnic groups within
industrialized populations in Europe (South Asians), North
America (African- and Hispanic Americans, Pima Indians)
or in Australasia (Australians Aborigines, New Zealand
Samoans) differ profoundly from those of European
descents in their risks for chronic diseases. He proposed a
metabolic ‘load vs. capacity’ model of disease, based on the
thrifty phenotype hypothesis of developmental program-
ming, whereby a number of components of organ structure
and function that scale positively with birth weight track
through development into adult life, and may hence under-
lie the long-term health effects of early life growth variabil-
ity. In this ‘load-capacity’ model, the constituents of lean
body mass are proposed to contribute to ‘metabolic capac-
ity’, a generic trait favouring the maintenance of homeos-
tasis, whereas adiposity (i.e. fat mass) is proposed to
contribute to ‘metabolic load’ which at higher levels chal-
lenges metabolic homeostasis, elevating cardiometabolic
risks. The topic of ethnic variability in cardiometabolic
risks is analysed from the perspective of ecological and
evolutionary origins in body composition and metabolism,
including adaptation of body size and physique to climate
and thermal environment (heat stress vs. cold stress), short-
and long-term food availability (quantity and quality), as
well as adaptation to infections – with the contention that
ethnic variability in both adipose tissue distribution and
cytokine biology may indeed reﬂect differential exposure to
infectious diseases.
Portal theory vs. ectopic fat theory
There are numerous studies, albeit in population groups
of European or South Indian ancestries, that do in fact
support the concept of a speciﬁc role for intra-abdominal
fat accumulation (often referred to as visceral obesity) in
the link between abdominal obesity and insulin resistance,
with the mechanisms attributed to the release of free fatty
acids (FFAs) from visceral fat depots, which, by draining
into the portal vein, would exert adverse effects on hepatic
metabolism. There is, however, no clear proof of such a
causal link between visceral adiposity and insulin resist-
ance. Both are in fact common correlates of subcutaneous
abdominal adipose tissue accumulation, which, on the
basis of its considerably larger mass than visceral fat, could
have a greater potential to contribute to insulin resistance
through the release of FFAs into the systemic circulation
(3). While the issues of regional adipose tissue in the patho-
physiology of obesity continue to be a subject for debate,
the turn of the 21st century has been marked by a shift in
the attractiveness of the ‘portal theory’ in favour of the
‘ectopic fat theory’ which proposes that an important
causative link between excess fat and the metabolic syn-
drome resides in the excessive accumulation of lipids
outside ‘classical’ adipose tissue depots, i.e. in or around
organs and tissues that constitute the lean body mass (skel-
etal muscle, heart, liver, pancreas and kidneys). Indeed,
small intracellular reserve of lipids for essential ‘housekeep-
ing’ functions in non-adipocytes – such as for the mainte-
nance of membrane structure, ﬂuidity and intracellular
signalling – is tightly regulated, and if overloaded would
lead to cell dysfunction (lipotoxicity) and lipid-induced
programmed cell death (lipoapoptosis) (4).
These two theories, however, are not mutually exclusive.
As discussed by Item and Konrad in their revisit to the
portal theory, the role of ectopic fat storage in the devel-
opment of insulin resistance and cardiometabolic risks is in
accordance with the portal theory because a low storage
capacity of portally drained adipose tissue may oversupply
the liver with lipids, resulting in ectopic fat accumulation.
They emphasized that because intra-abdominal adipose
tissue comprises different fat depots and that not all of
these depots surround internal (visceral) organs or are
drained by the portal vein, their distinct anatomic and
functional properties pertaining to lipogenesis, lipolysis
and secretion of adipokines and pro-inﬂammatory
cytokines should be kept in mind when analysing function
and metabolism of different intra-abdominal depots. The
overall conclusion is that although the relative contribution
of FFA from visceral fat to the systemic circulation is low,
the direct exposure of the liver to increasing amounts of
FFAs and/or pro-inﬂammatory factors released from vis-
ceral adipose tissue directly into the portal vein contribute
importantly to the plausibility of the portal theory for
explaining the development of hepatic insulin resistance,
steatosis and inﬂammation.
Mechanisms of ectopic lipotoxicity
How ectopic fat storage leads to lipotoxicity and organ
dysfunction continues to be an area of intense investiga-
tions. Lipotoxicity is believed to occur when fatty acid in
excess of the oxidative needs spillover into harmful path-
ways of non-oxidative metabolism, these being linked to
the accumulation of metabolically active lipid intermedi-
ates, e.g. diacylglycerols (DAG), ceramides, long-chain
fatty acyl-CoAs and acylcarnitines. DAG in particular has
been shown to inhibit the insulin signalling cascade in
several cell systems and animal models, but its role in the
mechanisms by which lipid overload leads to insulin resist-
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ance in humans is equivocal. Following a critical review of
the evidence for and against a role of DAG in the develop-
ment of human muscle insulin resistance, Amati empha-
sized the need for assessing DAG beyond ‘total DAG’ as
DAG exists as distinct molecular species and stereoiso-
forms varying in chain lengths and degree of saturation and
are located in different cellular compartments (cytoplasmic
membrane, organelle membranes and lipid droplets). Con-
sequently, the heterogeneity and dynamic nature of DAG
need to be explored in order to identify which DAG moiety
and which subcellular localization of DAG subpopulations
is (and is not) involved in the pathogenesis of muscle insulin
resistance and impaired glucose homeostasis.
The ectopic fat storage theory has also been advanced
to explain the mechanisms by which obesity may lead
to impaired protein synthesis and muscle functions. In
addressing this topic, Guillet et al. ﬁrst reviewed the litera-
ture about the consequences of excessive adipose tissue and
their secretions (FFAs, pro-inﬂammatory cytokines) on
skeletal muscle ﬁbre types and contractility, and discussed
how changes in muscle typology could impact upon its
metabolic capacity in obesity, such as lower oxidative
capacity associated with decreased lipid oxidation, thereby
favouring an increase in fat storage. They subsequently
integrated emerging evidence in support of the notion that
as obesity progresses to a state when adipose tissue expand-
ibility reaches its limits and the burden of fat storage is
shifted to other organs/tissues, the resulting lipid inﬁltra-
tion in skeletal muscle, together with the secretion of pro-
inﬂammatory cytokines from the expanded adipose mass,
leads to insulin resistance and metabolic inﬂammation –
which impair not only glucose and lipid metabolism but
also protein synthesis, thereby contributing to the clinical
manifestation of sarcopenia, particularly in the elderly.
Obesity and ageing are also independent risk factors for
cardiovascular diseases, but there is growing evidence that
obesity and ectopic fat storage accelerate the ageing process
and exacerbate age-associated cardiovascular diseases. In
their analysis of molecular mechanisms that might be impli-
cated in the pathologies common to obesity, ageing and
cardiovascular diseases, Yang and Ming provided a com-
prehensive review of the evidence suggesting that sustained
hyperactive mTOR signalling (as opposed to intermittent
signalling) plays a crucial role in connecting metabolic
stress, ageing and cardiovascular diseases through the
stimulation of oxidative stress and inﬂammatory responses.
A mechanistic molecular model is proposed in which in
response to chronic positive energy balance, sustained
and persistent mTOR signalling is not only a molecular
pathway that contributes to the development of obesity and
promotes the ageing process, but one which also constitutes
a common molecular pathway through which both obesity
and ageing predisposes to metabolic inﬂammation, sarco-
penia and increased cardiometabolic risks.
Metabolic inﬂammation and thermogenesis
That obesity predisposes to metabolic inﬂammation is now
well recognized, but whether a state of low-grade inﬂam-
mation can predispose to obesity is much less clear, amidst
a large literature suggesting that cytokines and other
inﬂammatory factors released during sepsis or injury can
alter thermogenesis, and emerging evidence in rodents that
low-grade inﬂammation occurs in the hypothalamus and
locally induces resistance to leptin and insulin may be early
events in the development of obesity (5). In reviewing this
topic from a perspective of molecular pathways linking
metabolic inﬂammation and thermogenesis, Solinas ﬁrst
emphasized the intricate bidirectional interactions between
the immune system and the sympathetic nervous system
(SNS) by underlining (i) the actions that the SNS exerts on
white blood cells to control immunity and the ability of
leukocytes themselves to produce catecholamines, which,
along with cytokines, regulate the intensity of the immune
response, and (ii) the actions that the innate immune system
exerts on SNS control of thermogenesis and core body
temperature through the release of cytokines and other
signalling molecules. After a comprehensive review of the
molecular pathways implicated in innate immunity that
may also be involved in energy balance and weight home-
ostasis, it is concluded that the complex signalling network
recruited during metabolic inﬂammation exerts a balanced
action on the modulation of thermogenesis and energy
balance, with some pathways inhibiting thermogenesis
(and promoting weight gain), whereas other pathways have
opposite actions. Consequently, as the author points out,
there could be potential limitations and pitfalls in exploit-
ing inﬂammatory pathways to treat obesity, and that
immunomodulation of metabolic inﬂammation, rather
than an anti-inﬂammatory intervention aiming at its sup-
pression, may be a more promising strategy to increase
thermogenesis for the treatment or prevention of obesity
and its associated diseases.
To date, however, the only established molecular effector
of thermogenesis – whether in response to sepsis, cold or
diet – is the mitochondrial protein UCP1 that uncouples
oxidative phosphorylation in brown adipose tissue (BAT),
a tissue whose presence and function in adult humans have
long been debatable. In recent years, investigations into the
potential role of BAT in the control of thermogenesis in
adult humans have been revitalized by investigations using
positron emission tomography coupled to computed tom-
ography scanning, which have revealed the presence of
substantial amount of active BAT in the neck and shoulder
region in response to relatively mild cold exposure. Conse-
quently, research towards understanding the molecular
pathways involved in its disappearance during growth and
how it can be recruited and activated may lead to thera-
peutic targets. In this context, the fact that brown adi-
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pocytes can be found within white fat depots, and that they
are recruited in response to cold, catecholamines and other
factors released into the circulation from skeletal muscle or
heart during exercise (6), have led to a model of different
‘types’ of brown adipocytes: classical brown adipocytes,
which are derived from the myoblast lineage, and brown-
like adipocytes, which are either derived from precursors
residing within white adipose tissue or directly transdiffer-
entiated from white adipocytes, the latter being referred to
as recruitable ‘brite’ or ‘beige’ adipocytes. In this supple-
ment, Smorlesi et al. reviewed the recent advances about
the origin of both white and brown adipocytes and the
evidence in support of the ‘transdifferentiation theory’ in
which these two cell types with opposing functions and
contained in varying proportions in multiple fat depots
forming the adipose organ can reciprocally convert to each
other under appropriate stimuli in order to better satisfy
important physiological needs of the organism, including
thermogenesis (during cold exposure), energy storage (in
obesity) or energy release (during lactation). They argued
that the ‘browning’ effects of the adipose organ can be
useful to combat obesity and the metabolic syndrome not
only because brown adipocytes are more ‘healthy’ than
white adipocytes but also because the simple size reduction
of white adipocytes that characterizes the ﬁrst steps of
transdifferentiation can be useful in determining how to
avoid triggering adipocyte death based on critical size and
the consequent development of metabolic inﬂammation as
a result of macrophage inﬁltration. They highlight the mol-
ecules and signalling pathways involved in the switching of
adipocyte phenotype and conclude that a better under-
standing of the molecular mechanisms on the basis of
white-brown transdifferentiation can be useful to exploit
new therapeutic strategies to combat the increasing inci-
dence of metabolic diseases.
Thrifty metabolic traits
The resurgence of interest in the biology of BAT, a tissue
whose primary function is to produce heat for thermoregu-
latory thermogenesis, has also revived old questions and
debates about the importance of thermal regulation and
adaptive thermogenesis in the aetiology of human obesity.
As Landsberg reminds us, the issues of whether a low core
temperature could constitute a thrifty trait that contributes
to metabolic susceptibility to obesity and/or resistance to
therapeutic slimming have never been adequately addressed
in humans. After underlining the high price that mammals
have to pay for the maintenance of homeothermy (40–50%
of 24-h energy expenditure) and the individual variation
around the average set point for core temperature, he
reviews the evidence that this central set point can be
regulated in the interest of energy conservation, and argues
that if a lower basal core temperature or a lower tempera-
ture in response to lower energy intake is shown to inﬂu-
ence the metabolic economy of the obese, this would
constitute a physiological rationale for considering core
temperature as a therapeutic target in obesity management.
This brings us to another hotly debated issue in human
energy metabolism: how important is regulated heat pro-
duction (i.e. adaptive thermogenesis) in weight homeostasis
and obesity development? Unlike core temperature, which
is easily and precisely measured without the needs for
adjusting body size and body composition, adaptive ther-
mogenesis is not a measurable entity, but is calculated from
the parameters of energy balance and body composition,
with each parameter’s measurement error accumulating in
its calculation. In their critical review on this topic, Dulloo
et al. ﬁrst addressed the question of ‘what constitutes adap-
tive thermogenesis’ when examining the impact of altered
plane of nutrition on changes in the various compartments
of energy expenditure, and then discussed the various limi-
tations that can lead to over- or underestimations in its
assessment, including deﬁnitional and semantics, technical
and methodological, analytical and statistical. Despite all
these limitations and issues that blur its potential signiﬁ-
cance in metabolic susceptibility to obesity, it is undeniable
that the concept of adaptive thermogenesis has been (and
will continue to be) a major driving force for research into
mechanistic links between diet/lifestyle, weight dynamics
and disease entities of the metabolic syndrome, and for
opening new exciting research avenues towards managing
obesity and chronic metabolic diseases.
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